Idorsia (LTS:0RQE) Change In Inventory : CHF-49.5 Mil (TTM As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Idorsia Change In Inventory?

Idorsia's change in inventory for the quarter that ended in Sep. 2023 was CHF-3.4 Mil. It means Idorsia's inventory increased by CHF3.4 Mil from Jun. 2023 to Sep. 2023 .

Idorsia's change in inventory for the fiscal year that ended in Dec. 2022 was CHF-42.5 Mil. It means Idorsia's inventory increased by CHF42.5 Mil from Dec. 2021 to Dec. 2022 .

Idorsia's Total Inventories for the quarter that ended in Sep. 2023 was CHF60.3 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Idorsia's Days Inventory for the quarter that ended in Sep. 2023 was 3,622.22.

Inventory Turnover measures how fast the company turns over its inventory within a year. Idorsia's Inventory Turnover for the quarter that ended in Sep. 2023 was 0.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Idorsia's Inventory-to-Revenue for the quarter that ended in Sep. 2023 was 0.72.

Idorsia Change In Inventory Historical Data

The historical data trend for Idorsia's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Change In Inventory Chart

Idorsia Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

-42.54

Idorsia Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Inventory	Get a 7-Day Free Trial															-4.38	-16.28	-25.67	-4.16	-3.38

Idorsia Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-49.5 Mil.

Idorsia (LTS:0RQE) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Idorsia's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	57.4395	/	1.447	*	365 / 4
	=	3,622.22

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Idorsia's Inventory Turnover for the quarter that ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.447	/	57.4395
	=	0.03

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Idorsia's Inventory to Revenue for the quarter that ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	57.4395	/	79.917
	=	0.72

Idorsia Change In Inventory Related Terms

Thank you for viewing the detailed overview of Idorsia's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia (LTS:0RQE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (LTS:0RQE) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

IDRSF:USA IDIAz:UK IDIA:Switzerland

Address

Hegenheimermattweg 91, Allschwil, CHE, 4123

Website

https://www.idorsia.com

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.

Idorsia (LTS:0RQE) Headlines

No Headlines